课题基金 / 基金详情

ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION

ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
腺病毒 243R E1A 蛋白和细胞转录
批准号:
2895049
负责人:
DANIEL A ENGEL
金额:
$10.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-04-17 至 2000-03-31

项目摘要

项目成果

DANIEL A ENGEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Important insights into the mechanisms of human carcinogenesis have come from the study of DNA tumor viruses. The DNA tumor virus adenovirus provides an ideal system for investigating transcriptional events in cellular transformation. The long-term goal of our research is to understnd the mechanism by which the adenovirus E1A protein alters the normal cellular transcriptional program so as to induce transformation. Here, we focus on the transcriptional regulation of the cellular c-fos gene by the adenovirus 243R E1A protein, and the functional interaction between E1A and the cellular transcriptional machinery. Our previous studies have identified a link between the action of E1A and an important intracellular signling system, the cAMP-dependent protein kinase pathway. This interaction results in the activation of a set of genes that are involved in cellular growth control and transformation. Knowledge gained from studying the effects ofE1A on cellular transcriptional regulation wil lead to better understanding of the molecular events involved in transformation. 1) Identifiction transacting factors involved in the activation of c-fos by E1A and cAMP, A 22 nucleotide "E1A-response element" (ERE) has been identified that mediates activation of c-fos by the 243R E1A protein. The ERE contains binding sites for transcription factors ATF/CREB and YY1. Factors tht bind the ERE will be identified, and the effects of E1A and cAMP on their level and activity will be determined. 2) Structure and function of the ATF/CREB-YY1 complex. YY1 physically interacts with members of the AFT/CREB family of transcription factors. As a prelude to investigating the role of the ATF/CREB-YY1 complex in activation b E1A, structure/function analysis of the ATF/CREB-YY1 interaction will be performed. DNA-binding and transcriptional repression by the complex will also be investigated. 3) The ATF/CREB-YY1 complex as a target ofE1A. E1A can bind to YY1 and alter its DNA-binding properties. The interaction between E1A and YY1, and between E1A and the ATF/CREB-YY1 complex will e studied. Experiments will include structure/function analysis of the E1A-YY1 interaction, as well as in itro and in vivo binding assays. These experiments will lead to a model for the molecular basis of E1a activation of thec-fos gene.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Adenovirus E1A243 disrupts the ATF/CREB-YY1 complex at the mouse c-fos promoter.
腺病毒 E1A243 破坏小鼠 c-fos 启动子处的 ATF/CREB-YY1 复合物。
DOI: 10.1128/jvi.69.12.7402-7409.1995
发表时间: 1995
期刊: Journal of virology
影响因子: 5.4
作者: [Zhou,Q, Engel,DA]
通讯作者: Engel,DA
Adenovirus E1A specifically blocks SWI/SNF-dependent transcriptional activation.
腺病毒 E1A 特异性阻断 SWI/SNF 依赖性转录激活。
DOI: 10.1128/mcb.16.10.5737
发表时间: 1996
期刊: Molecular and cellular biology
影响因子: 5.3
作者: [Miller,ME, Cairns,BR, Levinson,RS, Yamamoto,KR, Engel,DA, Smith,MM]
通讯作者: Smith,MM
Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32.
腺病毒蛋白 VII 在整个早期阶段发挥作用,并与细胞蛋白 SET 和 pp32 相互作用。
DOI: 10.1128/jvi.79.4.2474-2483.2005
发表时间: 2005
期刊: Journal of virology
影响因子: 5.4
作者: [Xue,Yuming, Johnson,JeffreyS, Ornelles,DavidA, Lieberman,Judy, Engel,DanielA]
通讯作者: Engel,DanielA
Human SWI-SNF component BRG1 represses transcription of the c-fos gene.
人类 SWI-SNF 成分 BRG1 抑制 c-fos 基因的转录。
DOI: 10.1128/mcb.19.4.2724
发表时间: 1999
期刊: Molecular and cellular biology
影响因子: 5.3
作者: [Murphy,DJ, Hardy,S, Engel,DA]
通讯作者: Engel,DA
Small molecule inhibitors of influenza virus nucleoprotein
  • 批准号:
    10255568
  • 项目类别:
  • 资助金额:
    $30.0万
  • 财政年份:
    2021
  • 负责人:
    DANIEL A ENGEL
  • 依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
  • 批准号:
    8277243
  • 项目类别:
  • 资助金额:
    $83.53万
  • 财政年份:
    2010
  • 负责人:
    DANIEL A ENGEL
  • 依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
  • 批准号:
    8466918
  • 项目类别:
  • 资助金额:
    $76.44万
  • 财政年份:
    2010
  • 负责人:
    DANIEL A ENGEL
  • 依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
  • 批准号:
    8661106
  • 项目类别:
  • 资助金额:
    $82.68万
  • 财政年份:
    2010
  • 负责人:
    DANIEL A ENGEL
  • 依托单位:
海外基金